Controlling Neuroinflammation In Alzheimers Disease
Grant number: 1044714 | Funding period: 2013 - 2015
Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.
Related publications (2)
Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury
Ila P Karve, Moses Zhang, Mark Habgood, Tony Frugier, Kate M Brody, Maithili Sashindranath, C Joakim Ek, Stephane Chappaz, Ben T Kile, David Wright, Hong Wang, Leigh Johnston, Maria Daglas, Robert C Ates, Robert L Medcalf, Juliet M Taylor, Peter J Crack